Evidence map›Paper›PMID 26701823›Full record

ArticleCell cycle (Georgetown, Tex.)2016

Cohesin's role in pluripotency and reprogramming.

Preksha Gupta, Thais Lavagnolli, Hegias Mira-Bontenbal, Amanda G Fisher, Matthias Merkenschlager

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Preksha Guptaa Lymphocyte Development Group, MRC Clinical Sciences Center, Faculty of Medicine, Imperial College London , London , UK.
Thais Lavagnollia Lymphocyte Development Group, MRC Clinical Sciences Center, Faculty of Medicine, Imperial College London , London , UK.
Hegias Mira-Bontenbala Lymphocyte Development Group, MRC Clinical Sciences Center, Faculty of Medicine, Imperial College London , London , UK.
Amanda G Fishera Lymphocyte Development Group, MRC Clinical Sciences Center, Faculty of Medicine, Imperial College London , London , UK.
Matthias Merkenschlagera Lymphocyte Development Group, MRC Clinical Sciences Center, Faculty of Medicine, Imperial College London , London , UK.
Imperial College London · GB

Funding

Medical Research Council MC_U120027516Wellcome Trust 099276
6 · The paper itself

Abstract

Cohesin is required for ES cell self-renewal and iPS-mediated reprogramming of somatic cells. This may indicate a special role for cohesin in the regulation of pluripotency genes, perhaps by mediating long-range chromosomal interactions between gene regulatory elements. However, cohesin is also essential for genome integrity, and its depletion from cycling cells induces DNA damage responses. Hence, the failure of cohesin-depleted cells to establish or maintain pluripotency gene expression could be explained by a loss of long-range interactions or by DNA damage responses that undermine pluripotency gene expression. In recent work we began to disentangle these possibilities by analyzing reprogramming in the absence of cell division. These experiments showed that cohesin was not specifically required for reprogramming, and that the expression of most pluripotency genes was maintained when ES cells were acutely depleted of cohesin. Here we take this analysis to its logical conclusion by demonstrating that deliberately inflicted DNA damage - and the DNA damage that results from proliferation in the absence of cohesin - can directly interfere with pluripotency and reprogramming. The role of cohesin in pluripotency and reprogramming may therefore be best explained by essential cohesin functions in the cell cycle.

Indexed as

Cellular ReprogrammingCell Cycle CheckpointsCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsDNA DamageEmbryonic Stem CellsHumansInduced Pluripotent Stem CellsNuclear ProteinsPhosphoproteinsRNA InterferenceCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsNuclear ProteinsPhosphoproteinsRAD21 protein, humancell cyclecohesinenhancer-promoter interactionsgene expressionpluripotencyreprogrammingstress

Identifiers

PMID26701823
PMCPMC4943700
OpenAlexW2215817432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.